FEBS Press

SHERPA: Unknown

People

  1. Weigelt
    Weigelt
  2. Nandakumar
    Nandakumar
  3. Selenica
    Selenica
  4. Brogi
    Brogi
  5. Norton
    Norton
  6. Abu-Rustum
    Abu-Rustum
  7. Giri
    Giri
  8. Jungbluth
    Jungbluth
  9. Aghajanian
    Aghajanian
  10. Berger
    Berger

Groups

  1. Sloan Kettering Institute Postdocs (17)
  2. GSK Faculty (16)
  3. Department of Medicine (13)
  4. Solid Tumor Oncology Division (12)
  5. Department of Pathology and Laboratory Medicine (11)
  6. GDMT, Pathology and Laboratory Medicine (9)
  7. Gynecology Disease Management Team (9)
  8. Surgery (8)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Breast Medicine Service (5)
Search Within
Formats
  1. Journal Article (33)
  2. Editorial (2)
Groups
  1. Sloan Kettering Institute Postdocs (17)
  2. GSK Faculty (16)
  3. Department of Medicine (13)
  4. Solid Tumor Oncology Division (12)
  5. Department of Pathology and Laboratory Medicine (11)
  6. GDMT, Pathology and Laboratory Medicine (9)

More Groups

People
  1. Britta Weigelt (9)
  2. Jorge Reis-Filho (9)
  3. Kiu Yan Charlotte Ng (7)
  4. Salvatore Piscuoglio (5)
  5. Philip Kantoff (4)
  6. Pier Selenica (4)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (6)
  5. 2021 (2)
  6. 2020 (3)

More Years

Publications
  1. Molecular Oncology (35)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas
    Journal Article

    Frydendahl, A.; Widman, A. J.; Øgaard, N.; Arora, A.; Halmos, D.; Nors, J.; Ahrenfeldt, J.; Henriksen, T. V.; Demuth, C.; Raaby, L.; more...
    Molecular Oncology (2025)

    Fulltext@MSK | Save
  • ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype
    Journal Article

    Brodeur, M. N.; Selenica, P.; Ma, W.; Moufarrij, S.; Dagher, C.; Basili, T.; Abu-Rustum, N. R.; Aghajanian, C.; Zhou, Q.; Iasonos, A.; more...
    Molecular Oncology (2024)

    Fulltext@MSK | Save
  • Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23–24, 2023
    Editorial

    Ringborg, U.; von Braun, J.; Celis, J.; Baumann, M.; Berns, A.; Eggermont, A.; Heard, E.; Heitor, M.; Chandy, M.; Chen, C. J.; more...
    Molecular Oncology (2024)

    Fulltext@MSK | Save
  • Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
    Journal Article

    Novoplansky, O.; Shnerb, A. B.; Marripati, D.; Jagadeeshan, S.; Abu Shareb, R.; Conde-López, C.; Zorea, J.; Prasad, M.; Ben Lulu, T.; Yegodayev, K. M.; more...
    Molecular Oncology (2023)

    Fulltext@MSK | Save
  • Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer
    Journal Article

    Celada, S. I.; Li, G.; Celada, L. J.; Lu, W.; Kanagasabai, T.; Feng, W.; Cao, Z.; Salsabeel, N.; Mao, N.; Brown, L. K.; more...
    Molecular Oncology (2023)

    Fulltext@MSK | Save
  • From bedside to portable and wearable: Development of a conformable ultrasound patch for deep breast tissue imaging
    Editorial

    Burgess, M. T.; Gluskin, J.; Pinker, K.
    Molecular Oncology (2023)

    Fulltext@MSK | Save
  • Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness
    Journal Article

    Kvokačková, B.; Fedr, R.; Kužílková, D.; Stuchlý, J.; Vávrová, A.; Navrátil, J.; Fabian, P.; Ondruššek, R.; Ovesná, P.; Remšík, J.; more...
    Molecular Oncology (2023)

    Fulltext@MSK | Save
  • Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer
    Journal Article

    Yoshikawa, Y.; Stopsack, K. H.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Burton, F.; Chakraborty, G.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancers
    Journal Article

    Favre, L.; Cohen, J.; Calderaro, J.; Pécriaux, A.; Nguyen, C. T.; Bourgoin, R.; Larnaudie, L.; Dupuy, A.; Ollier, M.; Lechapt, E.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
    Journal Article

    Mazzu, Y. Z.; Liao, Y.; Nandakumar, S.; Sjöström, M.; Jehane, L. E.; Ghale, R.; Govindarajan, B.; Gerke, T. A.; Lee, G. S. M.; Luo, J. H.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save

    • FEBS Press – authorized name for: